Role of the Autonomic Nervous System in HIV-Lipodystrophy

This study has been completed.
HW&J Hector-Stiftung
Information provided by:
Hannover Medical School Identifier:
First received: September 6, 2005
Last updated: May 6, 2008
Last verified: May 2008
The study aims to characterise the influence of the autonomic nervous system activity on the development of the lipodystrophy syndrome in HIV-infected patients by measuring heart rate variability and various metabolic pathways in HIV patients receiving highly active antiretroviral therapy.

HIV Infections

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Autonomic Nervous System Activity in the Pathogenesis of the Lipodystrophy Syndrome in HIV-Infected Patients.

Resource links provided by NLM:

Further study details as provided by Hannover Medical School:

Biospecimen Retention:   Samples Without DNA
Serum and Plasma

Enrollment: 54
Study Start Date: March 2005
Study Completion Date: January 2007

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with confirmed HIV infection and no active opportunistic infection during the last 2 months.

Inclusion Criteria:

  • HIV-infection
  • Age above 18 years
  • No AIDS defining event during last 6 months
  • No infection during last 6 weeks
  • No concommitant drug interfering with insulin sensitivity and ANS-activity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00149097

Hannover Medical School
Hannover, Germany, 30625
Sponsors and Collaborators
Hannover Medical School
HW&J Hector-Stiftung
Principal Investigator: Georg MN Behrens, MD Hannover Medical School
  More Information

Responsible Party: Prof. Georg Behrens, Hannover Medical School Identifier: NCT00149097     History of Changes
Other Study ID Numbers: ANS-M26
Study First Received: September 6, 2005
Last Updated: May 6, 2008
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:
Lipid Metabolism Disorders
Metabolic Diseases
Skin Diseases
Skin Diseases, Metabolic processed this record on November 27, 2015